Launched at the World Economic Forum in January 2020, ‘Ambition Zero Carbon’ is AstraZeneca’s commitment to achieving zero carbon emissions from its global operations by 2025 and having a carbon negative value chain by 2030. By 2025, AstraZeneca will double its energy productivity; use 100% renewable energy for power and heat, eliminate F-gas emissions from its sites, launch next-generation respiratory inhalers to treat asthma and Chronic Obstructive Pulmonary Disease (COPD) with near-zero climate impact propellants and plant 50 million trees under the ‘AZ Forest’ programme. AstraZeneca was the first pharmaceutical company to be a member of all three of the Climate Group’s RE100, EV100 and EP100 initiatives.
The company’s Scope 1 and 2 greenhouse gas emission reduction targets have been verified by the Science-Based Targets Initiative as being consistent with reductions required to keep warming to 1.5°C, the most ambitious goal of the Paris Agreement.
‘AZ Forest’ – Alongside the work to eliminate carbon emissions from its operations and value chain, AstraZeneca recognises the direct link between reforestation and the impact it can have on both the climate and human health. Trees naturally remove CO2 and are essential to mitigate the effects of climate change. ‘AZ Forest’ is a reforestation initiative where 50-million trees will be planted by 2025, with longer term stewardship to ensure their permanence. In partnership with local governments and One Tree Planted, a non-profit organisation focused on biodiversity and reforestation, the first trees were planted in Australia in September 2020, followed by planting in Indonesia and France. AstraZeneca is an early supporter of the World Economic Forum’s 1T.org trillion trees platform.